Anxiety and Related Sleep Disorders - Switzerland

Revenue in the Anxiety and Related Sleep Disorders market is projected to reach US$85.17m in 2024.
Revenue is expected to show an annual growth rate (CAGR 2024-2029) of -0.52%, resulting in a market volume of US$82.97m by 2029.
In global comparison, most revenue will be generated United States (US$3.21bn in 2024).
In relation to total population figures, per person revenues of US$110.30 are generated in 2024.

The Anxiety and Related Sleep Disorders market covers sales of three drug classes: anxiolytics, hypnotics, and sedatives. These classes contain different types of drugs, such as benzodiazepines, anticonvulsants, and antihistamines, that reduce anxiety and insomnia symptoms caused by anxiety. These medications mainly fall into the category of prescription drugs.

Market values represent the revenues generated by manufacturers and are based on retail prices for each drug category including all drugs, regardless of whether they are reimbursed or not.

Company examples: Pfizer, Bristol-Myers Squibb, GlaxoSmithKline PLC, Johnson & Johnson, and Merck & Co.

Pharmaceutical sales and consumption of anxiolytics
Pharmaceutical sales and consumption hypnotics and sedatives

Non-mental health related sleep disorders
Any other anxiety medications
Psychotherapy

The Anxiety and Related Sleep Disorders market in Switzerland has been experiencing significant growth in recent years.

Customer preferences: Swiss consumers are increasingly seeking solutions for anxiety and sleep disorders, as awareness of mental health issues continues to grow. The demand for effective treatments and therapies has led to a surge in the availability of products and services in the market. Customers are looking for convenient and accessible options that can help them manage their anxiety and improve their sleep quality. They are also more inclined towards natural and holistic approaches, leading to a rise in the popularity of alternative therapies and herbal remedies.

Trends in the market: One of the key trends in the Anxiety and Related Sleep Disorders market in Switzerland is the increasing adoption of digital health solutions. Mobile applications and online platforms that offer mental health support and sleep tracking have gained significant traction among consumers. These digital tools provide personalized recommendations and guidance, making it easier for individuals to manage their anxiety and sleep disorders from the comfort of their own homes.Another trend in the market is the growing demand for natural and plant-based remedies. Swiss consumers are increasingly turning to herbal supplements, such as valerian root and lavender, which are known for their calming and sleep-inducing properties. The popularity of these natural remedies can be attributed to the increasing preference for organic and sustainable products.

Local special circumstances: Switzerland is known for its high standard of healthcare and the availability of a wide range of treatment options. The country has a well-developed healthcare system, which includes specialized clinics and hospitals that cater to individuals with anxiety and sleep disorders. This accessibility to quality healthcare services has contributed to the growth of the market.Furthermore, Switzerland has a high level of disposable income and a strong culture of wellness and self-care. This has created a favorable environment for the growth of the Anxiety and Related Sleep Disorders market, as consumers are willing to invest in products and services that can improve their mental well-being.

Underlying macroeconomic factors: The growing prevalence of anxiety and sleep disorders can be attributed to various macroeconomic factors. Switzerland has a highly competitive and demanding work environment, which often leads to high levels of stress and anxiety among individuals. Additionally, the fast-paced and technology-driven lifestyle has resulted in an increase in sleep disorders, as people struggle to disconnect and relax.The COVID-19 pandemic has also had a significant impact on the Anxiety and Related Sleep Disorders market in Switzerland. The uncertainty and stress caused by the pandemic have heightened mental health issues, leading to an increased demand for anxiety and sleep disorder treatments. The pandemic has also accelerated the adoption of digital health solutions, as people seek remote support for their mental well-being.In conclusion, the Anxiety and Related Sleep Disorders market in Switzerland is experiencing growth due to increasing customer preferences for convenient and holistic solutions, the adoption of digital health tools, and the availability of quality healthcare services. The local special circumstances, such as the high standard of healthcare and the culture of wellness, further contribute to the market's development. The underlying macroeconomic factors, including the demanding work environment and the impact of the COVID-19 pandemic, have also fueled the growth of the market.

Data coverage:

Data encompasses B2C enterprises. Figures are based on companies' revenues, international institutes data, and global consumer survey data. Revenues refer to the retail value and include sales taxes.

Modeling approach / Market size:

Market sizes are determined by a combined top-down and bottom-up approach, based on a specific rationale for each market market. As a basis for evaluating markets, we use financial reports and third-party data. Next, we use relevant key market indicators and data from country-specific associations such as healthcare spending per capita, medical product spending per capita, and gross domestic product per capita. This data helps us to estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, S-Curve function, ARIMA time series model and exponential curve function. Data is modeled using current exchange rates.

Additional Notes:

The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level. GCS data is reweighted for representativeness.

This report presents a comprehensive analysis and additional information on the Health market, in a PDF format.

Despite what some may think, mental health problems are common in the United States and around the world. Mental health issues, much like other health issues, can be mild, but can also be life altering, affecting the emotional, social, and psychological well-being of the person. Common types of mental illness include mood disorders, anxiety disorders, eating disorders, and personality disorders. Although symptoms of mental illness differ depending on the type of illness and seriousness of the problem, common symptoms of mental health issues include changes in sleeping and eating habits, social withdrawal, feelings of hopelessness, anger, and prolonged sadness, suicidal thoughts, and substance abuse. In 2022, it was estimated that around 36 percent of those in the U.S. aged 18 to 25 years and 29 percent of those aged 26 to 49 years suffered from some form of mental illness in the past year.